KR20230131180A - 뉴로멜라닌-민감성 mri 및 이의 사용 방법 - Google Patents

뉴로멜라닌-민감성 mri 및 이의 사용 방법 Download PDF

Info

Publication number
KR20230131180A
KR20230131180A KR1020237020192A KR20237020192A KR20230131180A KR 20230131180 A KR20230131180 A KR 20230131180A KR 1020237020192 A KR1020237020192 A KR 1020237020192A KR 20237020192 A KR20237020192 A KR 20237020192A KR 20230131180 A KR20230131180 A KR 20230131180A
Authority
KR
South Korea
Prior art keywords
neuromelanin
disease
mri
alzheimer
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237020192A
Other languages
English (en)
Korean (ko)
Inventor
사무엘 클라크
클리포드 캐시디
페드로 로사-네토
케네스 웽글러
기예르모 호르가 에르난데스
Original Assignee
테란 바이오사이언시스 인코포레이티드
유니버시티 오브 오타와 인스티튜트 오브 멘탈 헬스 리서치
더 로얄 인스티튜션 포 디 어드밴스먼트 오브 러닝/맥길 유니버시티
더 로얄 인스티튜션 포 디 어드밴스먼트 오브 러닝/맥길 유니버시티
더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕
더 리서치 파운데이션 포 멘탈 하이진, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 테란 바이오사이언시스 인코포레이티드, 유니버시티 오브 오타와 인스티튜트 오브 멘탈 헬스 리서치, 더 로얄 인스티튜션 포 디 어드밴스먼트 오브 러닝/맥길 유니버시티, 더 로얄 인스티튜션 포 디 어드밴스먼트 오브 러닝/맥길 유니버시티, 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕, 더 리서치 파운데이션 포 멘탈 하이진, 인크. filed Critical 테란 바이오사이언시스 인코포레이티드
Publication of KR20230131180A publication Critical patent/KR20230131180A/ko
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/20—ICT specially adapted for the handling or processing of medical images for handling medical images, e.g. DICOM, HL7 or PACS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
    • A61B5/004—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
    • A61B5/0042—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4842—Monitoring progression or stage of a disease
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Data Mining & Analysis (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Psychiatry (AREA)
  • Developmental Disabilities (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Databases & Information Systems (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nuclear Medicine (AREA)
KR1020237020192A 2020-11-16 2021-11-16 뉴로멜라닌-민감성 mri 및 이의 사용 방법 Pending KR20230131180A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063114304P 2020-11-16 2020-11-16
US63/114,304 2020-11-16
US202063120105P 2020-12-01 2020-12-01
US63/120,105 2020-12-01
US202163277490P 2021-11-09 2021-11-09
US63/277,490 2021-11-09
PCT/US2021/059590 WO2022104288A1 (en) 2020-11-16 2021-11-16 Neuromelanin-sensitive mri and methods of use thereof

Publications (1)

Publication Number Publication Date
KR20230131180A true KR20230131180A (ko) 2023-09-12

Family

ID=81602654

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237020192A Pending KR20230131180A (ko) 2020-11-16 2021-11-16 뉴로멜라닌-민감성 mri 및 이의 사용 방법

Country Status (9)

Country Link
US (1) US20230389854A1 (https=)
EP (1) EP4243684A4 (https=)
JP (2) JP2023549712A (https=)
KR (1) KR20230131180A (https=)
AU (1) AU2021377338A1 (https=)
CA (1) CA3199469A1 (https=)
IL (1) IL302831A (https=)
MX (1) MX2023005649A (https=)
WO (1) WO2022104288A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230281804A1 (en) * 2020-07-31 2023-09-07 Koninklijke Philips N.V. Landmark detection in medical images
JP2024510080A (ja) 2021-03-11 2024-03-06 テラン バイオサイエンシズ インコーポレイテッド バイオマーカーを含む撮像データセットのハーモナイゼーションのためのシステム、デバイス及び方法
TW202333668A (zh) 2021-12-15 2023-09-01 美商德利克斯醫療公司 經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途
WO2023235766A2 (en) * 2022-05-31 2023-12-07 University Of Ottawa Institute Of Mental Health Research Methods for acquiring and analyzing neuromelanin-sensitive mri
CN117095815B (zh) * 2023-07-20 2025-05-27 中国人民解放军海军军医大学第一附属医院 基于磁共振图像和病理全景扫描切片预测带有同源重组缺陷的前列腺癌患者的系统
CN117078638A (zh) * 2023-08-22 2023-11-17 深圳湾实验室 一种图像处理方法、装置及电子设备
TWI877875B (zh) * 2023-10-31 2025-03-21 中國醫藥大學附設醫院 腦部斷層掃描電腦輔助偵測系統、方法及電腦程式產品
CN117690537B (zh) * 2024-02-04 2024-06-18 中日友好医院(中日友好临床医学研究所) Qsm与脑萎缩、脑连接组关联的跨模态方法及装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288545B1 (en) * 1999-03-22 2001-09-11 General Electric Company Method and apparatus for calibration of RF and gradient field time delays
EP2844143B1 (en) * 2012-05-04 2023-07-19 Emory University Method for imaging and determining information associated with regions of the brain
KR102025356B1 (ko) * 2017-11-17 2019-09-25 울산과학기술원 뇌에 존재하는 철의 시각화를 위한 방법
EP3766042B1 (en) * 2018-03-14 2025-05-07 Emory University Systems and methods for generating biomarkers based on multivariate mri and multimodality classifiers for disorder diagnosis
EP3863505A4 (en) * 2018-10-10 2022-08-17 The Trustees of Columbia University in the City of New York SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR NEUROMELANINSENSITIVE MAGNETIC RESONANCE IMAGING AS A NON-INVASIVE PROXY MEASURE OF DOPAMINE FUNCTION IN THE HUMAN BRAIN
CN111681184B (zh) * 2020-06-09 2023-02-24 复旦大学附属华山医院 一种神经黑色素图像重建方法、装置、设备和存储介质

Also Published As

Publication number Publication date
AU2021377338A9 (en) 2024-09-12
AU2021377338A1 (en) 2023-06-01
EP4243684A1 (en) 2023-09-20
JP2026066253A (ja) 2026-04-16
WO2022104288A1 (en) 2022-05-19
MX2023005649A (es) 2023-09-27
CA3199469A1 (en) 2022-05-19
EP4243684A4 (en) 2025-03-12
IL302831A (en) 2023-07-01
JP2023549712A (ja) 2023-11-29
US20230389854A1 (en) 2023-12-07

Similar Documents

Publication Publication Date Title
US20230389854A1 (en) Neuromelanin-sensitive mri and methods of use thereof
US20260007323A1 (en) Neuromelanin-sensitive mri for assessing parkinson's disease
Landin-Romero et al. Disease-specific patterns of cortical and subcortical degeneration in a longitudinal study of Alzheimer's disease and behavioural-variant frontotemporal dementia
Guzman et al. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment
Okkels et al. Severe cholinergic terminal loss in newly diagnosed dementia with Lewy bodies
Sabbagh et al. Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia
Tripathi et al. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT
Sala et al. Vulnerability of multiple large‐scale brain networks in dementia with Lewy bodies
Walker et al. Non-Alzheimer’s dementia 2: Lewy body dementias
David et al. New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease
US10534052B2 (en) FMRI biomarker of neurodegenerative disease
Kuhlmann et al. Time for a new mechanism-driven framework to define multiple sclerosis progression
Tuovinen Investigating BOLD signal variability and its physiological signal sources in Alzheimer's disease, behavioral variant frontotemporal dementia, and schizophrenia
Lingo VanGilder et al. Using whole-brain diffusion tensor analysis to evaluate white matter structural correlates of delayed visuospatial memory and one-week motor skill retention in nondemented older adults: A preliminary study
Tosun et al. Profiling and predicting distinct tau progression patterns: An unsupervised data‐driven approach to flortaucipir positron emission tomography
Linden Neuroimaging and neurophysiology in psychiatry
CN116745858A (zh) 神经黑色素敏感性mri及其使用方法
Kraynak et al. A preliminary investigation of worry, cortical amyloid burden, and stressor-evoked brain and cardiovascular reactivity in older adults
Liu et al. Esketamine combined with sertraline for brain Altered Regional Homogeneity in patients with major depressive disorder: a preliminary study
Meadowcroft et al. 18F-FDG-PET hyperactivity in Alzheimer’s disease cerebellum and primary olfactory cortex
Aye Dual-phase PET imaging in cognitive impairment: an imaging study of amyloid and tau PET as measures of neurodegeneration and protein pathology
Aghourian-Namagerdy Clinical validation of [18F]-fluoroethoxybenzovesamicol used with positron emission tomography imaging for the detection and quantification of Alzheimer's disease on the basis of cortical cholinergic denervation
Mieling Functional and structural changes in the progression of Alzheimer's disease: insights from human imaging
Depierreux Multimodal Imaging in Parkinson’s Disease: Exploring Iron–, Neuromelanin-Sensitive MRI and FDOPA PET Relationships
Passamonti Tau pathology, microglia activation, and network dysfunction in Alzheimer’s disease

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000